Microbial inoculant technology that uses beneficial bacteria to improve rooting success in cuttings and in vitro cultures, targeting 50-80% reduction in propagation losses for ornamentals and crops.
Vegetative plant propagation through cuttings and in vitro cultures is widely used for crops and ornamentals, but it suffers from significant losses of 20-50% during the rooting phase due to abiotic stressors and disease pressure. This solution addresses that bottleneck by deploying specially selected and enhanced plant-associated bacteria that nurture cuttings and protect them against stress. Proof-of-concept trials in roses and chrysanthemums demonstrated rooting improvements of approximately 50% compared to untreated controls. The approach is designed to integrate into existing propagation workflows as a microbial inoculant treatment, offering a biological alternative or complement to conventional rooting hormones and fungicides.
The technology is at an early-to-mid stage of development. Proof-of-concept validation has been completed in two ornamental species with statistically significant rooting improvements. The next phase involves isolating bacteria from natural root environments, enhancing them through non-GMO experimental evolution, testing single strains and consortia on rose as the primary target, and optimizing the formulation of the most promising candidates. The project is calibrated to last one year and requires support for a dedicated technician plus partial coverage of laboratory and travel costs. The underlying science is grounded in published research, and the company has existing capabilities in microbiome engineering, high-throughput sequencing, bioinformatics, and predictive analytics to support development.
Cybiome GmbH is a life sciences company focused on engineering and optimizing natural microbial communities to address challenges in health, nutrition, and environmental sustainability. The company operates a discovery platform that integrates data sciences, mathematical modeling, and artificial intelligence to design microbiome-based solutions. Their core capabilities include high-throughput DNA sequencing, bioinformatics analysis, and the development of predictive algorithms for drug design and diagnostic reporting. By partnering with academic institutions, Cybiome provides comprehensive services ranging from soil health analysis and microbiome diagnostic reports to the design of novel formulations aimed at enhancing microbiome functionality.
These solutions are designed to support R&D initiatives for partners in sectors such as agriculture and biopharmaceuticals. By providing turnkey solutions for microbiome diagnostics and improvement, the company assists clients in accelerating innovation, supporting decision-making, and developing sustainable alternatives to traditional agricultural inputs like pesticides and fertilizers. Cybiome also participates in collaborative research, such as the Cousin project, where it contributes expertise in microbiome data processing and the identification of biomarkers to drive improvements in plant traits.